Surgery Partners, Inc. Common Stock earnings per share and revenue
On Nov 10, 2025, SGRY reported earnings of 0.13 USD per share (EPS) for Q3 25, missing the estimate of 0.16 USD, resulting in a -23.03% surprise. Revenue reached 821.50 million, compared to an expected 837.45 million, with a -1.90% difference. The market reacted with a -25.42% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of 0.32 USD, with revenue projected to reach 883.74 million USD, implying an increase of 146.15% EPS, and increase of 7.58% in Revenue from the last quarter.
FAQ
What were Surgery Partners, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Surgery Partners, Inc. Common Stock reported EPS of $0.13, missing estimates by -23.03%, and revenue of $821.50M, -1.9% below expectations.
How did the market react to Surgery Partners, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -25.42%, changed from $21.50 before the earnings release to $16.04 the day after.
When is Surgery Partners, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 02, 2026.
What are the forecasts for Surgery Partners, Inc. Common Stock's next earnings report?
Based on 14
analysts, Surgery Partners, Inc. Common Stock is expected to report EPS of $0.32 and revenue of $883.74M for Q4 2025.